Considering aesthetic surgery? You need to do your research and become an informed consumer.

Home

Search

Article Archive

Resources / Links

Aesthetic Surgery Books

Skin Care Store

Free Newsletter



Information about Anti-Aging Products and Their Active Ingredients
Read more here

Skin Medica TNS Recovery Complex

WRINKLE RELAX
aka Faux-Tox

Home Micro
dermabrasion

Z. BIGATTI

Strivectin Eye Cream
Gentle for the under-eye area.

FREEZE 24/7 with GABA

FREEZE 24/7 LIP PLUMPER

FREEZE 24/7 Ice Cream

FREEZE 24/7 Eye Cream

CITY LIPS LIP PLUMPER

MD FORTE FACIAL CREAM

MD FORTE FACIAL CLEANSER

Celebrity Plastic Surgery  Celebrity Cosmetic Surgery  Whose Had it??
Find out here!

Bion Ceramic Flat Iron
HAI Ceramic Flat Iron
Solia Ceramic Flat Iron
SEDU Ceramic Flat Iron
CHI Ceramic Flat Iron

ELA-Max Numbing Cream

GoSMILE TOOTH WHITENING
Home Kit!

PRESCRIPTIVES

KINERASE

FROWNIES HOLLYWOOD'S BEST KEPT SECRET

PERRICONE SKIN CARE PRODUCTS

ORIGINS

RICAUD
Available straight from Paris!

HAIRMAX LASER COMB

TRUE COSMETICS BEING TRUE


Dermisonics Introduces Novel U-Wand Technology
Company Engineers Cosmeceutical Delivery Device

(press release from Dermisonics, Inc.)

This article sponsored by:
BUY all your Cosmeceuticals here!
Microdermabrasion Kits, PREVAGE, True Cosmetics, FREEZE 24/7, DR.Brandt Crease Release, Kinerase, Strivectin, Obagi, Z.Bigatti, M.D. Forte, Dermanew, DDF Wrinkle Relax, Cellex-C, City Lips, TNS Recovery Complex, FREE SHIPPING, FREE SAMPLES!!

WEST CONSHOHOCKEN, Penn., June 21 -- Dermisonics, Inc. (DMSI.OB), an ultrasound device company, announced that it has commenced the development of a new handheld cosmetics delivery device called the U-Wand. The Company has leveraged its expertise in ultrasonic drug delivery to develop a device intended for non-pharmaceutical, topical use with cosmetics. The U-Wand utilizes ultrasound to enhance the penetration and effect of various cosmetics.

The Company has developed four distinct design concepts for the U-Wand depending on the application. Two of these target larger application areas for the entire body; one is intended for facial application while the fourth is a hybrid model for face and large area application. The models are either battery powered or charged by a removable power cord.

The introduction of the U-Wand represents entry into an entirely new market opportunity for the Company in the realm of consumer products with an initial focus on cosmetics. Bruce Haglund, Chairman and CEO of Dermisonics commented, "We believe the application of our ultrasound technology to cosmetics represents a significant new opportunity for the Company. Our purpose is to develop innovative methods for the application of cosmetics and to foster their acceptance and use by consumers. We also hope to use these innovative devices as a platform to form a strategic alliance with a major cosmetics company."

About Dermisonics, Inc.

Dermisonics Inc. is a specialized medical and cosmetic device company that is primarily focused on the ongoing development, testing and eventual commercialization of a transdermal patch that has been designed to facilitate the efficient and needle-free delivery of heavy molecular drugs into the system. The U-Strip(TM) is a drug delivery system incorporating a transdermal patch in combination with microelectronics and ultrasonic technology. Tests have shown that this system facilitates the transdermal delivery of Insulin as well as potentially at least 175 other existing drugs that at present cannot be effectively delivered through the pores of the skin using conventionally available transdermal technology due to their large molecular size.

The Company is also dedicated to the development of other portable ultrasonic devices for applications with cosmetics and cosmeceuticals.

 

For further information contact Bruce Haglund, CEO.
bruce.haglund@dermisonics.com

Dermisonics, Inc.
Four Tower Bridge
200 Bar-Harbor Drive
West Conshohocken, Pa. 19428-2977 USA
888-401-DERM (3376) Toll Free
610-941-2780 Phone
610-941-2990 Fax

North American Investor Relations Contact:

John Robinson
Phone: 866-559-1333
johnrobinson@currentcapital.com

European Investor Relations Contact:

Michael Drepper
Phone: +49-621-430-6130
investor-germany@dermisonics.com

For additional information, please visit www.dermisonics.com

Legal Notice Regarding Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, unexpected costs and operating deficits, increases in general and administrative costs, termination of contracts or agreements, technological obsolescence of the Company's products, technical problems with the Company's research and products, price increases for supplies and components, litigation and administrative proceedings involving the Company, the possible acquisition of new businesses or that result in operating losses or that do not perform as anticipated, unanticipated losses, the possible fluctuation and volatility of the Company's operating results, financial condition and stock price, losses incurred in litigating and settling cases, dilution in the Company's ownership of its business, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists, changes in interest rates, inflationary factors, and other specific risks. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-QSB and Form 10-KSB filings with the Securities and Exchange Commission.


Knowledge is Power. Information is How You Get It!

 

CLARISONIC
Get The Most Popular Facial Skin Cleansing System for 1/2 the price, The LOWEST Price on the internet!!

HOME LASER HAIR REMOVAL
Created by the same scientists who made in-office laser hair removal a success

BABY QUASAR
50% off sale!! Home laser light photo rejuvenation therapy; in the privacy of your home correct the signs of sun damage, age spots, wrinkles and acne.



Do you want to advertise on this site? Click for details...

BETTER THAN BOTOX??

PLAZAN
Jennifer Lopez has revealed her skin care secret!

PREVAGE

MD FORTE
DERMANEW
OBAGI
DERMABLEND
SkinCeuticals

IDEBENONE

Mason Pearson Hair Brushes

Photolagen - AGF

Winsor Pilates

AlphaDerma CE

DR BRANDT
CREASE RELEASE

DR BRANDT
MICRO
DERMABRASION IN A JAR

ZENO

Cellulean Cellulite Treatment

DuWop LIP VENOM

Interesting Articles On: 
Buttock Augmentation

Perlane For Under-Eye Hollows

Fat Transfer

Feather Lift

Vaginal Plastic Surgery

Bullhorn Liplift

Treating Acne Scars

Type in your search words below


 

All contents copyright ©2000-2017 - Cosmetic Surgery News - All rights reserved.
Disclaimer
Privacy Policy